Saturna Capital Corp Lowers stake in VCA Inc (WOOF)

VCA Inc (WOOF) : Saturna Capital Corp reduced its stake in VCA Inc by 0.98% during the most recent quarter end. The investment management company now holds a total of 620,000 shares of VCA Inc which is valued at $45,005,800 after selling 6,148 shares in VCA Inc , the firm said in a disclosure report filed with the SEC on Aug 8, 2016.VCA Inc makes up approximately 1.38% of Saturna Capital Corp’s portfolio.

Other Hedge Funds, Including , Moors Cabot added WOOF to its portfolio by purchasing 3,600 company shares during the most recent quarter which is valued at $261,324. VCA Inc makes up approx 0.04% of Moors Cabot’s portfolio. Sheaff Brock Investment Advisors added WOOF to its portfolio by purchasing 17,285 company shares during the most recent quarter which is valued at $1,237,606. VCA Inc makes up approx 0.15% of Sheaff Brock Investment Advisors’s portfolio.Sg Americas Securities reduced its stake in WOOF by selling 2,154 shares or 7.77% in the most recent quarter. The Hedge Fund company now holds 25,559 shares of WOOF which is valued at $1,803,699. VCA Inc makes up approx 0.01% of Sg Americas Securities’s portfolio. Quadrant Capital Group added WOOF to its portfolio by purchasing 29 company shares during the most recent quarter which is valued at $2,069.Chase Investment Counsel Corp reduced its stake in WOOF by selling 480 shares or 3.91% in the most recent quarter. The Hedge Fund company now holds 11,810 shares of WOOF which is valued at $818,669. VCA Inc makes up approx 0.35% of Chase Investment Counsel Corp’s portfolio.

VCA Inc opened for trading at $72.87 and hit $73.655 on the upside on Monday, eventually ending the session at $73.39, with a gain of 1.33% or 0.96 points. The heightened volatility saw the trading volume jump to 6,64,902 shares. Company has a market cap of $5,935 M.

On the company’s financial health, VCA Inc reported $0.87 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.82. The company had revenue of $653.49 million for the quarter, compared to analysts expectations of $637.18 million. The company’s revenue was up 19.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.70 EPS.

VCA Inc. is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company provides communication marketing solutions and other services to the veterinary community. The Company’s animal hospital offer general medical and surgical services pharmaceutical products and performs pet wellness programs. The Company’s communication and marketing solutions business provides services to veterinary practices pharmaceutical manufacturers and the pet owning community. The Company’s network of veterinary diagnostic laboratories provides sophisticated testing and consulting services.

Leave a Reply

VCA Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on VCA Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.